Skip to content Skip to footer

PharmaShots Magazine-March-2026 Edition

Shots AI is transforming clinical trial oversight from periodic monitoring to continuous, real-time intelligence, enabling early detection of safety signals, protocol deviations, and operational risks while strengthening data integrity and patient protection. Advanced analytics and machine learning are powering predictive, risk-based monitoring, integrating data from decentralized trials, wearables, ePROs, and multiple clinical systems to prioritize…

Read more

PharmaShots Magazine-January-2026 Edition

Shots: Amid rising R&D costs and tighter timelines, AI has evolved from a supporting tool to a central driver of biopharma deal-making, discovery strategies, and long-term value creation AI-led licensing deals, platform partnerships, and new valuation models are reshaping biotech–pharma collaborations, with platforms and proprietary datasets increasingly rivaling or surpassing traditional pipelines in deal value…

Read more